Switch to Combined GLP1 Receptor Agonist Lixisenatide with Basal Insulin Glargine in Poorly Controlled T2DM Patients with Premixed Insulin Therapy: A Clinical Observation and Pilot...

por Harreiter, Jürgen, Kosi-Trebotic, Lana, Lukas, Albert, Wolf, Peter, Winhofer, Yvonne, Luger, Anton, Kautzky-Willer, Alexandra, Krebs, Michael R.
Publicado 2017